21 results
8-K
EX-10.1
PTPI
Petros Pharmaceuticals Inc
15 Dec 20
Departure of Directors or Certain Officers
5:14pm
, including, without limitation, any other retention or bonus agreement, which is hereby terminated and cancelled and of no further force or effect, without
8-K/A
EX-10.1
PTPI
Petros Pharmaceuticals Inc
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
the Separation Date through June 30, 2021.
Retention of Computer – The Company agrees to permit Employee to retain Employee’s Company-issued lap-top
PRE 14A
b4nmybx6fp6 pbun
30 Sep 22
Preliminary proxy
4:45pm
DEF 14A
rxyjh 86l
22 Nov 21
Definitive proxy
4:37pm
8-K
EX-10.3
wonk1p3sfwsm4ddu0bdb
21 Jan 22
Entry into a Material Definitive Agreement
4:30pm
10-K
ei7uef4s75w5e1gul
31 Mar 21
Annual report
4:30pm
10-K
EX-10.1
9tye6zdk8hu948jfb
31 Mar 21
Annual report
4:30pm
8-K
EX-10.1
7um6biunrnv7
13 Jul 23
Petros Pharmaceuticals Announces Capital Raise of $15 million
4:41pm
424B3
1s2dfb0cdzv
14 Jan 22
Prospectus supplement
5:18pm
8-K
EX-3.1
dddp8 5ihn2a1
13 Jul 23
Petros Pharmaceuticals Announces Capital Raise of $15 million
4:41pm